SAINTE-FOY, QUEBEC -- (MARKET WIRE) -- November 02, 2006 -- Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer and supplier of taxane APIs and developer of targeted oncology drugs, is pleased to announce that it has filed its paclitaxel European Drug Master File (EDMF) in an additional four EU countries and also in Russia, bringing to fifteen the total number of countries in which the Corporation markets or plans to market its paclitaxel.
